Biological Innovations Revolutionizing Healthcare and Other Industries
CRISPR technologies hint at unfolding revolution as biology, data analytics and artificial intelligence intersect.
CRISPR technologies hint at unfolding revolution as biology, data analytics and artificial intelligence intersect.
Current inflation bumps result of COVID-19’s lingering impact, not out-of-control demand as many pundits suggest.
Key measures reflect a less vibrant third-quarter economic picture than many had hoped for.
Proposed cuts to Biden’s $3.5 trillion Build Back Better plan might not really be cuts.
Rising prices and elevated unemployment conjure up the specter of 1970s-style stagflation.
No longer mythical, unicorn companies are attracting late-stage investors looking to saddle up and ride them to glittering heights.
Floundering emerging markets likely to start swimming in 2022 as vaccinations increase and China pulls them out of economic deep water.
Full football stadiums means America’s economy has bounced back after being tackled by COVID-19, but problems will linger until the world is vaccinated.
The economy is still chugging away, but proposals to increase taxes and government spending raise concerns of a derailment that savvy investors need plan for—whether it happens or not.
If you earn $400,000 a year, beware—a tax proposal now before Congress would increase your risk of an IRS audit.